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Medicine is an evolving science and is an area of constant research. Although lot of things are already known, many things are yet unknown in this context. Due to 
the phenomenal improvement in the health-care system, there is 
a significant increase in life expectancy owing to non-invasive 
methods of the diagnosis, newer drugs, and the unprecedented 
technological advances in the treatment. However, drugs which 
are working today, might not work tomorrow due to phenomena 
of resistance. Hence, there is the need of applied research for 
developing new drugs, tests, imaging techniques, surgical 
modalities, etc especially, due to ever-increasing novel health 
issues that were not so critical earlier [1]. There is now a need 
for newer drugs with better efficacy and lesser side effects for 
the treatment and control of emerging diseases. We need newer 
treatment regimes for improved outcomes of diseases. Research is 
needed not only for identifying these new treatments or drugs but 
also for new devices and surgical techniques. This has to be tried 
and tested in the context of the disease epidemiology and health-
care delivery (health systems’ research). It is well documented 
that acceptance to medication also depends on the medical 
sociology, culture and anthropology, laws (legal medicine), and 
ethics (medical ethics) [2,3].
Medicine differs from mathematics and physics in the way 
that medicine does not have any blanket principles. Although 
there are general guiding principles that may be valid, each 
patient is different and every patient is an individual entity in its 
own. Although it may work for the majority, it might not be valid 
or effective to treat all the patients. A doctor often experiments 
the treatments in case of those patient who may not respond to 
the routine medications. Thus, medicine is experimental. This 
is true even for the routinely accepted treatments, wherein the 
response to the same treatment by every individual may vary. 
Hence, monitoring and evaluation of the treatment regimes of 
well-documented effective medicines is also required. This is the 
core of medical research [2].
EVIDENCE BASED MEDICAL PRACTICE
Physicians need to be updated about all the changes that occur 
continuously in the medical world. They have to keep reading 
and improving their knowledge of clinical research, based 
on the results of medical research; termed as evidence-based 
practice. Individual professionals need to be informed, trained, 
and motivated to be on the lookout of and incorporate the latest 
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evidence into their daily work [4]. However, trying to inculcate 
the same changes in their practice requires a basic understanding 
of research and its methods [2,5].
PHASES OF CLINICAL RESEARCH
Clinical trials are the mainstay of medical research for the 
practicing physicians [6]. Before a new drug can be approved 
by government-mandated regulatory authorities, it must undergo 
extensive testing for safety and efficacy. A research hypothesis 
is first established, following which, laboratory studies and 
animal studies are done. After such an extensive exercise, the 
pharmaceutical company has to get its approval to study various 
aspects of the drug in human beings. Once approved, the drug 
has to pass through four phases. In phase I, the drug is tried on 
a small number of human beings who volunteer and are paid in 
return. This phase is done to determine dosage, to know how the 
body processes the drug (pharmacokinetics) and to know the side 
effects. In phase II trial, the drug is used in patients with a particular 
disease to determine whether the drug has any beneficial effect 
and to know the side effects. In phase III, marketing of the drug is 
done and the drug is finally introduced into the market to compare 
it with other drugs and/or placebo. After the drug is marketed, it 
enters into phase IV called post-marketing surveillance to look 
for very long-term side effects [6].
ROLE OF A PHYSICIAN VIS-A-VIS A RESEARCHER
Because of the ever-increasing concept of evidence-based medical 
system, there has been a rapid rise in the number of clinical trials, 
which entail finding and recruiting large number of patients, as per 
the statistical requirements of the trials. Keeping the patients’ interest 
in mind, the physicians need to keep several potential problems at 
bay. This can be done by anticipating these problems and issues 
and trying to avoid them. A researcher is involved in the research 
in the first place; however, the role of a physician in the research 
is in stark contrast [5]. This is true in terms of the physician–
patient relationship, even if the physician and the researcher are 
the same person. The researcher is involved only in generating new 
knowledge, while the physician needs to consider the health and 
positive outcome for the patients. This gives rise to conflicting roles 
and duties; however, physicians’ role and patient commitment must 
supersede the role of researcher in such cases [5,7,8].
A potential issue in such cases is conflict of interest [9]. 
Participation in the medical research is a well-funded enterprise 
and physicians are sometimes offered considerable reward for 
participating. This includes monetary reward per subject enrolled, 
electronic items for data management, and sponsored conferences 
as well as authorship in publications of the results. These benefits 
may conflict with the physicians’ duty to provide the best possible 
treatment to the patients. The patients may not be fully informed 
about their rights of taking part in the results and/or the right to 
take informed decision of participation in the research or clinical 
trial. The ethical principles of the physician, i.e., autonomy, 
beneficence, and justice apply to the medical researcher as well. 
These need to be fully understood and duly followed by the 
physicians as well [10–12].
WHAT IS “THE ETHICAL” APPROACH?
There are broadly two approaches toward ethical issues: non-
rational (does not mean irrational, meaning reflective use of 
reason in decision-making) and rational.
NON-RATIONAL APPROACHES
Obedience
This is a common way of making decisions on ethical issues; 
especially, by children and those who work with authorization 
structures (e.g. military, air force). They follow the rules or instructions 
of those in authority, whether they agree with them or not [7,13,14].
Imitation
It subordinates one’s judgment about right and wrong to that of 
another person.
Feeling or Desire
It is a subjective approach to moral decision-making and behavior. 
It is variable from person to person and also from time to time in 
the same person.
Intuition
It is the immediate perception of the right way to act in a situation. 
It is entirely subjective.
Habit
It is an efficient method of moral decision-making. The advantage 
is that there is no need to repeat a systematic decision-making 
process each time a moral issue arises.
RATIONAL APPROACHES
Deontology
It involves a search for well-founded rules that can serve as the 
basis for making moral decisions. There are specific rules to be 
applied in specific situations.
Consequentialism
It bases ethical decision-making on an analysis of the likely 
consequences or outcomes of different choices and actions. The 
right action is the one that produces the best outcomes. One of 
the best-known forms of consequentialism is utilitarianism which 
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uses utility as its measure and defines this as “the greatest good 
for the greatest number.” Other measures include quality-adjusted 
life years or disability-adjusted life years.
Principalism
It uses ethical principles as the basis for making moral decisions. It 
helps to take decisions as per the situation, rules, and the consequences; 
helping to choose the right thing. In general, there are four principles; 
autonomy, beneficence, non-maleficence, and justice [15].
Autonomy
It requires that those who are capable of deliberation about their 
personal choices should be treated with respect for their capacity 
for self-determination.
Beneficence
It is ethical obligation to maximize the benefit and to minimize 
the harm.
Non-maleficence
It  means doing no harm or causing the least harm possible to 
achieve beneficial outcome.
Justice
It is an ethical obligation to treat each person in accordance with 
what is morally right and proper.
INFORMED CONSENT
It is the most important aspect in the medical ethics. It came 
into being; keeping in mind that due respect should be given 
to patients. In history, the first written consent was obtained by 
Dr. Walter Reed from the persons involved in his experiment [16].
Informed consent has four elements: disclosure, 
comprehension, voluntariness, and documentation [2].
Disclosure
Disclosure means informing/disclosing  the purpose, details of the 
procedure, duration of the study, its risks and benefits including 
monetary gains as well as alternative options and that they can 
discontinue their participation at any time. Providing all these details 
may need significant time on the part of researcher, so time constraint 
remains an important challenge to the disclosure. In addition to time, 
language and sociocultural barriers can prove to be a challenge.
Comprehension
It is the information to enable a potential participant to make an 
informed decision about whether to participate in a study is the 
responsibility of the researcher. Challenges to the comprehension 
are language barriers, extreme of ages, psychiatric illnesses, 
subjects with poor decision capacity or inability to fully 
comprehend, and inability to express one’s choice.
Voluntariness
It is an agreement or willingness to participate without undue 
influence. The consent for participation in research should be 
free of coercion and free of undue influence. In addition to undue 
influence, power dynamics and gender inequalities are challenges 
to the voluntariness.
Documentation
It should be written documentation of the informed consent. 
This should include the study summary and rights of research 
participant and should describe the whole informed consent 
process. As per the new regulations from Drug Controller 
General of India, for clinical trials of new chemical entity or a 
new molecular entity involving vulnerable subjects, audiovisual 
recording of consent process must be done [17].
INFORMED CONSENT AS A “PROCESS”
Informed consent is not an isolated event; it is an ongoing dialog 
between the investigator and the research subject. The investigator 
has a responsibility to address the participants’ concerns, to answer 
his questions, and to ensure that the patient has understood basic 
purpose of the study and study procedures.
Developments in Medical Research
Medical research ethics is an area of expertise which is fast 
evolving. It has also emerged as an area of debate over the 
past couple of decades. This is more so in case of transnational 
research collaborations, that is, research funded by institutions 
based in Europe and North America and implemented together 
with institutions in Latin America, Asia, Africa, and Eastern 
Europe. Transnational research often involves enrolling relatively 
poor study participants in less wealthy countries [18].
Concern regarding the ethics of medical science is not new. 
It is well known that the Nazis in Germany committed atrocities 
in the name of science and the African-Americans were denied 
treatment for syphilis in the Tuskegee trial [19]. Thus were born 
the ethical codes, namely, Nuremberg Code, the Declaration of 
Helsinki, and the Belmont Report [10]. The rising awareness about 
international human rights; rights based on the gender, prisoners, 
and the economic inequities have increasingly risen the public 
debate about science [20]. For the same reason, ethical review 
committees have come into existence to monitor the ethical part 
of the studies and the clinical trials.
Ethical Review Committee
It is of utmost importance now that each and every study is approved 
by an ethical committee. This committee oversees whether the 
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study is proposed and further conducted in an ethical manner 
and that it does not impinge on the ethical rights of the subjects 
or patients. It has different names in different countries such as 
Institutional Ethics Committee, Institutional Review Board, Ethics 
Review Board, and Research Ethics Board. Its responsibilities are 
to ensure a competent review of all the ethical aspects of the project 
proposals received by it in an objective manner, to look for the 
scientific soundness of the proposed research and its social value. 
The committee consists of 8–12 members from a multidisciplinary 
and multi-sectorial background [21]. A minimum of 5 persons are 
required to form a quorum to take a decision regarding research; 
especially, clinical trials [6].
Proportionate EC Review: Expedited/Full
Ethical review by the committee is subject to the type and nature 
of risks involved in the study. It should assess the risk and potential 
benefits of the research or trial. A balanced review is based on 
the “minimal risk concept” helping to decide whether a “full 
board review” or an “expedited review” is required. Minimal risk 
entails a condition where “The probability and magnitude of harm 
or discomfort anticipated in the research are not greater than those 
ordinarily encountered in daily life or during the performance of 
routine physical or psychological examinations or tests”.[22]
The decision to conduct an expedited review may be made 
by the chair of the EC while keeping all members informed 
about the studies approved by expedited review. All clinical 
trials are initially subject to a full EC review, and usually, the 
continuing review of trials must be conducted by the full EC. ECs 
differ in their views about whether continuing reviews, protocol 
amendments or alterations, safety reports, and multicentric studies 
are acceptable for expedited review or not [6].
Guidelines for Research on Human Subjects
1. Ask an answerable research question.
2. Pay attention to the study design.
3. Choose your subjects without bias.
4. Enhance benefits and minimize risks.
5. Respect your subject’s rights [6].
Approaches to Strengthening International Medical Research 
Ethics
The rising debate about medical research ethics can be answered 
by refining the regulations and guidelines, especially for the 
individual studies [23–26]. There is a felt need to build and expand 
the capacity of local and national bodies for monitoring the ongoing 
studies. This can be done more efficiently through ethics review 
committees and community advisory boards [12,25,27–32]. The 
existing codes have abstract and universal ethical principles 
which cannot be applied in all contexts for all the geographic 
areas. Therefore, local and national bodies can act as competent 
independent specialist bodies in research-related decision-
making; especially, in low-income settings [25,27,28,31].
There have been many improvisations in the arena of 
International Medical Research Ethics wherein, in India, it is 
now mandatory for all ethics committees which review and 
approve clinical trials to get registered with the Directorate 
General of Health Services and Central Drugs Standard Control 
Organization [33]. Under the Drug and Cosmetics Act, this central 
authority is responsible for the approval of new drugs, clinical 
trials in the country, laying down the standards for drugs, and 
control over the quality of imported drugs.
It is the responsibility of the investigator to report any 
untoward incidences such as adverse drug reactions (ADRs). 
The noxious effect of a drug when it is used in the recommended 
doses is an ADR; if the causal association is not proven, it is 
termed as an adverse event (AE). An AE or ADR leading to death, 
hospitalization or its prolongation, disability or incapacity is 
termed as a Serious Adverse Event (SAE). The ethics committee 
and regulatory body of the country are bound to uphold the ethical 
principles of the beneficence, justice, and non-maleficence in 
such cases. The principal investigator should report the SAE 
within 24 hours to DCGI, the sponsor, and the chairperson of the 
ethics committee. Ethics committees investigate and submit their 
report of SAE to the DCGI and accordingly, the compensation is 
decided by the DCGI [34,35]. Ethics committees are empowered 
to hold or stop the ongoing trials when felt necessary for the safety 
of study subjects. The ethics committees are also responsible for 
the monitoring the clinical trial sites periodically.
Clinical Trial Registration
Registration of trial before its initiation in publicly available 
trials registry (viz. Clinical Trials Registry of India) [36] has 
become mandatory in many countries. Free web-based access 
to the information about ongoing clinical trials is regarded as an 
important tool for the public. It also provides a complete picture of 
the past research, whether it was negative or successful (Cochrane 
registration or the Prospero website registration). This stands 
true for the systemic reviews also, which help in combining the 
results to come to one viewpoint or decision about the usefulness 
or the implementation of the drugs and medications. The ethics 
committee may be requested to monitor the compliance of the 
clinical trial registration according to the local regulations and 
policies.
Regulatory Authorities and Trial Registration
Since the late 1990s, drug regulatory authorities have put more 
emphasis on the need to publish essential information about the 
ongoing clinical trials on publicly searchable trial registries. 
This has been an explicit concern for those with life-threatening 
diseases, such as HIV/AIDS and cancer; since it would increase 
the possibility for the patients to identify trials for the participation. 
These diseases are worldwide, with the public health aspect being 
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more important and case based. US-FDA has made it mandatory 
to register phase II/III trials (not phase I), since the data implicates 
the application or introduction of the new drugs. Each trial must 
be registered before its onset, and there is a penalty system in 
place for the non-compliance.
Scientific Journals and Trial Registration
Since 2004, the International Committee of Medical Journal 
Editors has set up a policy enforcing the registration of the 
interventional trials (phases II-IV) in an accepted public trials 
registry to be considered for the publication in its journals [36]. 
The policy became mandatory in July 2005. The registration 
must take place before starting the patient enrolment. This policy 
has been extended to include phase I trials. However, only a few 
journals have adopted this policy. Most of the medical journals 
do not mention the policy in their instructions to the authors [6].
Unresolved Issues
There are certain aspects of the medical science which do not get 
a general consensus. In areas such as genetics, neurosciences, 
newer vaccines, organ and tissue transplant, and stem cell 
transplantation, there are no readymade answers for the 
questions arising. However, there have been some guidelines 
framed for the stem cell research and research in the children, 
recently [13,23,26]. Despite all these potential problems, the 
medical research is a valuable and rewarding activity for the 
physicians and medical students as well as for the research 
subjects themselves. These results when extrapolated have 
greater rewarding results for the general public. Every level, the 
individual or the committee, do face their own individual issues 
and problems. These need a case-based resolving approach [14]. 
A rising concern is the need for soft skills while interacting with 
the subjects; at the same time not encroaching on their ethical 
rights [37].
There is not much funding for the research-oriented work, 
and where it is there, they may sometimes be led by conflicts of 
the interest. Furthermore, there is inequity in the research health 
funding and diseases afflicting more than 90% of the world’s 
population get <10% of the global funding for the research. This 
disparity of more spending on diseases affecting the rich rather 
than poor countries is known as “the 10/90 gap” [38].
CONCLUSION
Medical Science is ever evolving and so medical ethics also 
needs to be flexible and open to change and adjustment, as 
indeed it has been for quite some time now. However, we hope 
that its basic principles will remain in place; especially, the 
values of compassion, competence, and autonomy, along with its 
concern for the fundamental human rights and its devotion to the 
professionalism.
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